John P. Kelley

This profile gathers the share dealings of John P. Kelley across 3 companies, led by Medicines Co /DE, Acorda Therapeutics Inc and Tenax Therapeutics, Inc. Between 3 January 2007 and 15 March 2017, the trades on record add up to 18 filings.

On the open market, the record shows 1 purchase worth €33k and 5 sales worth €2.3M. Taken together, the sales exceed the purchases by €2.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 7 share grants and 5 option exercises.

The latest filing, published on 20 March 2017, reports a share grant of €62k in Tenax Therapeutics, Inc. The last insider purchase was made public on 7 August 2007, 7,034 days ago. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.